Wenbin Lin Selected Research

pyrithione zinc (ZPT)

1/2022	Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.
1/2021	Nanoscale Metal-Organic Framework Confines Zinc-Phthalocyanine Photosensitizers for Enhanced Photodynamic Therapy.
12/2016	Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenbin Lin Research Topics

Disease

61	Neoplasms (Cancer) 01/2022 - 09/2008
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
8	Colonic Neoplasms (Colon Cancer) 10/2021 - 10/2009
6	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 04/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 12/2011
4	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
3	Breast Neoplasms (Breast Cancer) 11/2021 - 12/2016
3	Hyperaldosteronism (Conn Syndrome) 11/2021 - 01/2019
3	Hypoxia (Hypoxemia) 04/2020 - 01/2018
2	Thalassemia 01/2021 - 01/2018
2	Necrosis 12/2016 - 01/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015 - 12/2014
2	Carcinoma (Carcinomatosis) 05/2009 - 09/2008
1	Triple Negative Breast Neoplasms 11/2021
1	Bites and Stings (Sting) 01/2020
1	Carcinogenesis 07/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Iron Overload 01/2018
1	Anemia 01/2018

Drug/Important Bio-Agent (IBA)

16	Metal-Organic FrameworksIBA 01/2021 - 04/2014
14	PolymersIBA 01/2022 - 01/2012
13	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021 - 12/2014
10	Pharmaceutical PreparationsIBA 01/2022 - 01/2012
9	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
9	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 09/2008
6	LigandsIBA 06/2020 - 03/2012
5	Photosensitizing Agents (Photosensitizers)IBA 11/2021 - 12/2014
5	Therapeutic UsesIBA 10/2020 - 03/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020 - 12/2014
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2013
4	B7-H1 AntigenIBA 01/2022 - 01/2018
4	Carboplatin (JM8)FDA LinkGeneric 11/2021 - 01/2013
4	MetalsIBA 01/2021 - 01/2017
4	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2014
4	PlatinumIBA 01/2017 - 05/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2015
3	LipidsIBA 01/2022 - 01/2012
3	pyrithione zinc (ZPT)FDA Link 01/2022 - 12/2016
3	ProdrugsIBA 01/2022 - 01/2015
3	Neoplasm Antigens (Tumor Antigens)IBA 11/2021 - 01/2020
3	AldosteroneIBA 11/2021 - 01/2019
3	AntigensIBA 01/2021 - 01/2016
3	tributyl phosphate (TBP)IBA 01/2020 - 01/2018
2	Biological ProductsIBA 01/2021 - 07/2017
2	Hydroxyl RadicalIBA 04/2020 - 01/2020
2	ReninIBA 01/2020 - 01/2019
2	AntibodiesIBA 01/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
2	Gemcitabine FDA Link 11/2016 - 03/2015
2	Antineoplastic Agents (Antineoplastics)IBA 07/2016 - 08/2015
2	chlorinIBA 01/2016 - 06/2015
2	polysilsesquioxaneIBA 01/2015 - 10/2011
2	Diphosphonates (Bisphosphonates)IBA 12/2014 - 03/2012
2	Contrast MediaIBA 10/2013 - 12/2011
2	Lipid Bilayers (Lipid Bilayer)IBA 03/2012 - 01/2012
2	Peptides (Polypeptides)IBA 03/2012 - 12/2011
1	EsterasesIBA 01/2022
1	artenimol (dihydroartemisinin)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	IronIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	dimethylaminomicheliolideIBA 01/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2022
1	CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	zinc 1,4,8,11,15,18,22,25- octa- n- butoxyphthalocyanineIBA 10/2021
1	AcidsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	EndostatinsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Digitoxin FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	VaccinesIBA 10/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2020
1	Oxygen (Dioxygen)IBA 04/2020
1	CatalaseIBA 04/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	OligodeoxyribonucleotidesIBA 01/2020
1	Toll-Like Receptor 7IBA 01/2020
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2020
1	Singlet OxygenIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	InterferonsIBA 01/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2019
1	Hormones (Hormone)IBA 07/2019
1	CateninsIBA 01/2019
1	Carbon DioxideIBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018

Therapy/Procedure

23	Therapeutics 11/2021 - 10/2009
18	Immunotherapy 01/2022 - 01/2016
12	Drug Therapy (Chemotherapy) 11/2021 - 10/2011
11	Photochemotherapy (Photodynamic Therapy) 11/2021 - 12/2014
8	Radiotherapy 01/2022 - 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Intravenous Injections 11/2021
1	Phototherapy (Light Therapy) 01/2019
1	Blood Transfusion (Blood Transfusions) 01/2018